Emergence of Fosfomycin Resistance by Plasmid-Mediated <i>fos</i> Genes in Uropathogenic ESBL-Producing <i>E. coli</i> Isolates in Mexico

• Main Authors: Mario Galindo-Méndez (Author), Humberto Navarrete-Salazar (Author), Francisco Baltazar-Jiménez (Author), Eduardo Muñoz-de la Paz (Author), María Fernanda Sánchez-Mawcinitt (Author), Alexis Gómez-Pardo (Author), Elvira Garza-González (Author), Luis Alfredo Ponce- (Author), Rafael Franco-Cendejas (Author), Rayo Morfín-Otero (Author), Fabián Rojas-Larios (Author), Juan Pablo Mena-Ramírez (Author), Cecilia Teresita Morales- (Author), Lourdes García-Mendoza (Author), Elena Victoria Choy-Chang (Author), Laura Karina Avilés-Benítez (Author), Eduardo López-Gutiérrez (Author), Jorge Luis Canizales-Oviedo (Author), Nicolás Eric Barlandas-Rendón (Author), Joyarib Yanelli Maldonado-Anicacio (Author), Alina Aracely Rosales-García (Author), Heidy Leticia Ostos-Cantú (Author)
• Format: Book
• Published: MDPI AG, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Fosfomycin is currently a viable option against urinary tract infections, particularly against extended-spectrum β-lactamases (ESBL)-producing <i>E. coli</i>, due to its unique mechanism of action and its low resistance among bacteria. The objective of this study was to investigate two o...